Philip Poortmans

41.4k total citations · 11 hit papers
310 papers, 19.5k citations indexed

About

Philip Poortmans is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Philip Poortmans has authored 310 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Cancer Research, 114 papers in Oncology and 102 papers in Pathology and Forensic Medicine. Recurrent topics in Philip Poortmans's work include Breast Cancer Treatment Studies (165 papers), Breast Lesions and Carcinomas (77 papers) and Advanced Radiotherapy Techniques (69 papers). Philip Poortmans is often cited by papers focused on Breast Cancer Treatment Studies (165 papers), Breast Lesions and Carcinomas (77 papers) and Advanced Radiotherapy Techniques (69 papers). Philip Poortmans collaborates with scholars based in Netherlands, Belgium and France. Philip Poortmans's co-authors include Fátima Cardoso, Frédérique Penault‐Llorca, Elżbieta Senkus, S. Kyriakides, Sophia Zackrisson, Shinji Ohno, Laurence Collette, Giuseppe Curigliano, Michael Gnant and Harry Bartelink and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Philip Poortmans

294 papers receiving 19.1k citations

Hit Papers

Breast cancer 2001 2026 2009 2017 2019 2019 2015 2021 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Breast cancer
    2019 2.0k citations Frédérique Penault‐Llorca, Philip Poortmans et al. profile →
  2. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2019 1.4k citations Fátima Cardoso, S. Kyriakides et al. Annals of Oncology profile →
  3. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2015 1.2k citations Elżbieta Senkus, S. Kyriakides et al. Annals of Oncology profile →
  4. Breast cancer
    2021 1.0k citations Philip Poortmans et al. profile →
  5. Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
    2007 722 citations Harry Bartelink, Philip Poortmans et al. Journal of Clinical Oncology profile →
  6. Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
    2001 693 citations Harry Bartelink, Philip Poortmans et al. profile →
  7. Duration of Androgen Suppression in the Treatment of Prostate Cancer
    2009 658 citations Philip Poortmans et al. profile →
  8. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
    2005 582 citations Philip Poortmans et al. Journal of Clinical Oncology profile →
  9. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
    2015 485 citations Birgitte Vrou Offersen, Liesbeth Boersma et al. Radiotherapy and Oncology profile →
  10. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
    2019 438 citations Philip Poortmans, Martine Piccart et al. Annals of Oncology profile →
  11. Experimental Set-up for FLASH Proton Irradiation of Small Animals Using a Clinical System
    2018 203 citations Philip Poortmans et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Poortmans Netherlands 61 8.9k 7.1k 5.2k 4.6k 3.4k 310 19.5k
Harry Bartelink Netherlands 74 9.1k 1.0× 7.1k 1.0× 5.2k 1.0× 5.4k 1.2× 5.2k 1.5× 270 20.5k
Benjamin D. Smith United States 61 7.0k 0.8× 9.3k 1.3× 2.9k 0.6× 3.7k 0.8× 4.4k 1.3× 375 19.3k
Paolo Veronesi Italy 74 12.9k 1.5× 7.3k 1.0× 8.3k 1.6× 3.5k 0.7× 7.4k 2.1× 457 20.1k
Paul McGale United Kingdom 30 9.1k 1.0× 4.8k 0.7× 3.0k 0.6× 3.6k 0.8× 2.4k 0.7× 55 16.1k
Al B. Benson United States 94 5.5k 0.6× 18.9k 2.6× 4.5k 0.9× 8.7k 1.9× 8.7k 2.5× 492 31.0k
Bruce G. Haffty United States 71 10.7k 1.2× 8.1k 1.1× 5.7k 1.1× 3.0k 0.7× 4.0k 1.2× 538 20.6k
Steven E. Schild United States 66 2.0k 0.2× 8.0k 1.1× 2.2k 0.4× 12.1k 2.6× 4.9k 1.4× 637 21.9k
Melania Pintilie Canada 67 4.5k 0.5× 4.6k 0.6× 2.0k 0.4× 3.8k 0.8× 2.1k 0.6× 303 15.4k
R. Arriagada France 55 5.8k 0.7× 9.2k 1.3× 2.9k 0.6× 9.1k 2.0× 2.2k 0.6× 200 17.7k
Allen S. Lichter United States 56 3.8k 0.4× 3.7k 0.5× 2.1k 0.4× 4.0k 0.9× 2.0k 0.6× 159 11.2k

Countries citing papers authored by Philip Poortmans

Since Specialization
Citations

This map shows the geographic impact of Philip Poortmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Poortmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Poortmans more than expected).

Fields of papers citing papers by Philip Poortmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Poortmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Poortmans. The network helps show where Philip Poortmans may publish in the future.

Co-authorship network of co-authors of Philip Poortmans

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Poortmans. A scholar is included among the top collaborators of Philip Poortmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Poortmans. Philip Poortmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caluwé, Alex De, Kim Cao, Vincent Remouchamps, et al.. (2025). Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial. Radiotherapy and Oncology. 206. 110836–110836. 2 indexed citations
2.
Groheux, David, Sofia C. Vaz, Lioe‐Fee de Geus‐Oei, et al.. (2025). [ 18 F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer. Journal of Clinical Oncology. 43(17). 1942–1947.
3.
Roozendaal, Lori M. van, Johannes H.W. de Wilt, Thijs van Dalen, et al.. (2024). De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07). British journal of surgery. 111(4). 6 indexed citations
4.
Groheux, David, Sofia C. Vaz, Philip Poortmans, et al.. (2024). Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines. The Breast. 78. 103806–103806. 2 indexed citations
5.
Kaidar‐Person, Orit, Miri Sklair‐Levy, Rinat Bernstein‐Molho, et al.. (2024). Residual breast tissue after mastectomy and reconstruction: A substudy of the Spatial location of breast cancer local rECurRence aftEr masTectomy (SECRET) project. European Journal of Surgical Oncology. 50(11). 108607–108607. 2 indexed citations
6.
Vaz, Sofia C., J.P. Pilkington Woll, Fátima Cardoso, et al.. (2024). Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(9). 2706–2732. 30 indexed citations
7.
Marta, Gustavo Nader, et al.. (2024). Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys. Clinical and Translational Radiation Oncology. 46. 100752–100752. 5 indexed citations
8.
9.
Blommaert, Jeroen, Marijke De Saint‐Hubert, Tom Depuydt, et al.. (2023). Challenges and opportunities for proton therapy during pregnancy. Acta Obstetricia Et Gynecologica Scandinavica. 103(4). 767–774. 9 indexed citations
10.
Andratschke, Nicolaus, Jonas Willmann, Ane Appelt, et al.. (2022). European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology. 23(10). e469–e478. 87 indexed citations
11.
Kaidar‐Person, Orit, Philip Poortmans, Birgitte Vrou Offersen, et al.. (2021). A multidisciplinary approach for autologous breast reconstruction: A narrative (re)view for better management. Radiotherapy and Oncology. 157. 263–271. 9 indexed citations
12.
Bosma, Sophie C.J., Marlous Hoogstraat, Erik van Werkhoven, et al.. (2020). A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients. Radiotherapy and Oncology. 156. 127–135. 6 indexed citations
13.
Dodwell, David, Carolyn Taylor, Paul McGale, et al.. (2019). Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials. Cancer Research. 79. 7 indexed citations
14.
Maaren, Marissa C. van, Linda de Munck, Luc J. A. Strobbe, et al.. (2018). Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study. International Journal of Cancer. 144(2). 263–272. 109 indexed citations
15.
Prasanna, Thiru, Youlia Kirova, S. Alran, et al.. (2018). Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery. Critical Reviews in Oncology/Hematology. 134. 10–21. 10 indexed citations
16.
Maaren, Marissa C. van, Luc J. A. Strobbe, Marjolein L. Smidt, et al.. (2018). Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years. European Journal of Cancer. 102. 82–94. 18 indexed citations
17.
Schreuder, K., John H. Maduro, P.E.R. Spronk, et al.. (2018). Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors. Clinical Oncology. 31(4). 250–259. 12 indexed citations
18.
Bosch, Steven L., Guus M.J. Bökkerink, H.J. Braam, et al.. (2017). Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease. Radiotherapy and Oncology. 123(1). 147–153. 14 indexed citations
19.
Weber, Damien C., Yucai Wang, Robert C. Miller, et al.. (2014). Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro-Oncology. 17(4). 588–595. 71 indexed citations
20.
Senkus, Elżbieta, S. Kyriakides, Frédérique Penault‐Llorca, et al.. (2013). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 24. vi7–vi23. 350 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harry Bartelink Breakdown of academic impact, for papers by Benjamin D. Smith Breakdown of academic impact, for papers by Paolo Veronesi Breakdown of academic impact, for papers by Paul McGale Breakdown of academic impact, for papers by Al B. Benson Breakdown of academic impact, for papers by Bruce G. Haffty Breakdown of academic impact, for papers by Steven E. Schild Breakdown of academic impact, for papers by Melania Pintilie Breakdown of academic impact, for papers by R. Arriagada Breakdown of academic impact, for papers by Allen S. Lichter
Rankless by CCL
2026